Alcor Life Extension Foundation Delivers Williams Documents

PHOENIX, Ariz. (December 20, 2004)…Joe Waynick, Chief Executive Officer of Alcor Life Extension Foundation announced today that the Foundation has delivered all documents pertaining to Ted Williams, in accordance with a recent order of a Maricopa Superior Court, to the plaintiffs, Ted and Sam Williams. The final order of the Court was handed down on November 30 and, according to Waynick, the Foundation met with legal counsel to assess its options, ultimately deciding not to appeal the Court’s decision.

“Alcor is dedicated to preserving the confidentiality of our patients if they so request, or if requested by family members,” said Waynick. “Our goal in this matter was to respect the wishes of Mr. Williams, his children, and his personal representative. We realize, however, that the publicity associated with this case has already affected the privacy wishes of the family such that we now believe the family will not be able to enjoy privacy again until the documents are released and the matter put to rest.”

Waynick stressed that the Court’s decision applies only to the Williams matter and the Foundation will continue to work to protect the privacy concerns of its members and their families.

For the sake of clarification, the documentation mentioned in the above press release was delivered to plaintiff's attorney in Phoenix, Arizona.

About Alcor Life Extension Inc.

The Alcor Life Extension Foundation, a nonprofit organization founded in 1972, is the world leader in cryonics, and cryonics research and technology. Cryonics is the science of using ultra-cold temperatures to suspend and preserve human life. The intent is that technologically advanced scientific procedures will one day be available to revive cryopreserved humans and restore them to good health.

The promise of cryopreservation has taken a quantum leap forward with the ongoing development of molecular nanotechnology and the introduction of vitrification to Alcor’s protocols.

One use of nanotechnology is the expectation that cell-sized machines will be developed to repair damage or cure disease at the cellular level, including any potential damage that results from the cryopreservation processes.

Alcor performed its first human cryopreservation in 1976. Since then, Alcor has engaged in long-term patient care as well as cryopreservation procedures. Among Alcor’s scientific achievements is the use of advanced cryoprotectant formulas capable of achieving ice-free preservation, known as vitrification.

Today, Alcor is the only full-service cryonics organization in existence. Alcor has more than 697 members from around the world and 67 patients in cryostasis. For more information about Alcor and cryonics, visit

# # #